Diffuse Large B-Cell Lymphoma (DLBCL)

What is Diffuse Large B-Cell Lymphoma (DLBCL)?

Diffuse Large B-Cell Lymphoma  is a type of cancer that affects the lymphatic system, which is a vital part of the body's immune system. In DLBCL, abnormal B-cells, a type of white blood cell responsible for fighting infections,

multiply rapidly and uncontrollably. These cancerous cells can form tumors in lymph nodes throughout the body, leading to symptoms such as swollen lymph nodes, fever, night sweats, fatigue, and unexplained weight loss.

Side effects of Diffuse Large B-Cell Lymphoma (DLBCL):

Diffuse Large B-Cell Lymphoma  and its treatments can cause various side effects, which may vary from person to person. Common side effects include nausea, vomiting, hair loss, fatigue, increased risk of infections, and changes in appetite. It's essential to communicate any side effects you experience with your healthcare team, as they can provide support and guidance to manage them effectively.

How is Diffuse Large B-Cell Lymphoma (DLBCL) diagnosed?

Diagnosing Diffuse Large B-Cell Lymphoma typically involves a combination of medical history review, physical examination, imaging tests (such as CT scans or PET scans), and biopsy of an affected lymph node or tissue. These tests help confirm the presence of DLBCL and determine its stage, which is crucial for developing an appropriate treatment plan.

Potential treatments of Diffuse Large B-Cell Lymphoma (DLBCL):

Treatment for DLBCL in Germany is highly individualized and may include one or a combination of the following options:

• Chemotherapy: Chemotherapy is often the primary treatment for DLBCL and involves the use of powerful drugs to kill cancer cells. Different chemotherapy regimens may be used depending on factors such as the stage of the disease and overall health.

• Immunotherapy: Immunotherapy works by boosting the body's immune system to recognize and destroy cancer cells. Monoclonal antibodies, such as rituximab, are commonly used in combination with chemotherapy to treat DLBCL.

• Radiation therapy: Radiation therapy uses high-energy beams to target and destroy cancer cells. It may be used alone or in combination with other treatments to treat DLBCL, particularly in cases where the cancer has spread to specific areas of the body.

• Stem cell transplantation: In some cases, a stem cell transplant may be recommended, especially for patients with high-risk DLBCL or those who have relapsed after initial treatment. This procedure involves replacing diseased bone marrow with healthy stem cells to help the body produce new, healthy blood cells.

• Targeted therapy: Targeted therapies are drugs that specifically target cancer cells while sparing healthy cells, leading to fewer side effects. Drugs targeting specific genetic mutations or cellular pathways involved in DLBCL may be used alone or in combination with other treatments.

👉 Contact us for further information and receive acomplimentary consultation.